Top

Published in:

01-08-2007 | Topic Paper

Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer

Authors: M. H. Wink, J. J. M. C. H. de la Rosette, C. A. Grimbergen, H. Wijkstra

Published in: World Journal of Urology | Issue 4/2007

Abstract

The diagnosis of prostate cancer is based on histology. Prostate biopsies are obtained based on the triad of prostate specific antigen (PSA), digital rectal examination (DRE) and transrectal ultrasound. Because prostate biopsies still have a large percentage of negative outcomes, patient selection and biopsy direction need improvement. This paper describes the recent improvements in prostate cancer imaging, especially contrast-enhanced transrectal ultrasound.

Babaian RJ, Dinney CP, Ramirez EI, Evans RB (1993) Diagnostic testing for prostate cancer detection: less is best. Urology 41:421–425PubMedCrossRef

Beemsterboer PM, Kranse R, de Koning HJ, Habbema JD, Schroder FH (1999) Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). Int J Cancer 84:437–441PubMedCrossRef

Bleuzen A, Tranquart F (2004) Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 14(Suppl 8):53–62

Bogers HA, Sedelaar JP, Beerlage HP, de la Rosette JJ, Debruyne FM, Wijkstra H, Aarnink RG (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97–104PubMedCrossRef

de Jong N., Bouakaz A, Frinking P (2002) Basic acoustic properties of microbubbles. Echocardiography 19:229–240PubMedCrossRef

de Jong I, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ (2003) 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 44:32–38PubMedCrossRef

de Jong I, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ (2002) Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 42:18–23PubMedCrossRef

Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C, Myles J, Reuther AM, Klein EA (2004) Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 22:300–306PubMed

Dijkmans PA, Juffermans LJ, Musters RJ, van Wamel A, ten Cate FJ, van Gilst W, Visser CA, de Jong N, Kamp O (2004) Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr 5:245–256PubMedCrossRef

10.

Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 163:1144–1148PubMedCrossRef

11.

Eckersley RJ, Sedelaar JP, Blomley MJ, Wijkstra H, deSouza NM, Cosgrove DO, de la Rosette JJ (2002) Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 51:256–267PubMedCrossRef

12.

Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J (2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175:1605–1612PubMedCrossRef

13.

Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR (2003) Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 108:336–341PubMedCrossRef

14.

Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302PubMed

15.

Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, Canini R, Grigioni W, Boschi S, Marengo M, Pettinato C, Salizzoni E, Monetti N, Franchi R, Fanti S (2005) Detection and localization of prostate cancer: correlation of 11C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46:1642–1649PubMed

16.

Flanigan RC, McKay TC, Olson M, Shankey TV, Pyle J, Waters WB (1996) Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 48:428–432PubMedCrossRef

17.

Fowler JE Jr, Bigler SA, Miles D, Yalkut DA (2000) Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 163:813–818PubMedCrossRef

18.

Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H, Schuster A, Horninger W, Rogatsch H, Bartsch G (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167:1648–1652PubMedCrossRef

19.

Futterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, Hulsbergen-van de Kaa CA, Witjes JA, Krabbe PF, Heerschap A, Barentsz JO (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458PubMedCrossRef

20.

Futterer JJ, Heijmink SWTP, Scheenen TWJ, Jager GJ, Van de Kaa CAH, Witjes JA, Barentsz JO (2006) Prostate cancer: local staging at 3-T endorectal MR imaging––early experience. Radiology 238:184–191PubMedCrossRef

21.

Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H (2003) The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 43:124–131PubMedCrossRef

22.

Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Invest Radiol 3:356–366PubMedCrossRef

23.

Halpern EJ, Frauscher F, Strup SE, Nazarian LN, O’Kane P, Gomella LG (2002) Prostate: high-frequency Doppler US imaging for cancer detection. Radiology 225:71–77PubMedCrossRef

24.

Halpern EJ, Frauscher F, Strup SE, Nazarian LN, O’Kane P, Gomella LG (2002) Prostate: high-frequency Doppler US imaging for cancer detection. Radiology 225:71–77PubMedCrossRef

25.

Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG (2005) Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 104:2373–2383PubMedCrossRef

26.

Halpern EJ, Rosenberg M, Gomella LG (2001) Prostate cancer: contrast-enhanced us for detection. Radiology 219:219–225PubMed

27.

Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V (2005) Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62:140–147PubMedCrossRef

28.

Hernandez J, Thompson IM (2004) Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101:894–904PubMedCrossRef

29.

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30PubMedCrossRef

30.

Jhaveri FM, Klein EA, Kupelian PA, Zippe C, Levin HS (1999) Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 17:3167–3172PubMed

31.

Karaman CZ, Unsal A, Akdilli A, Taskin F, Erol H (2005) The value of contrast enhanced power Doppler ultrasonography in differentiating hypoehoic lesions in the peripheral zone of prostate. Eur J Radiol 54:148–155PubMedCrossRef

32.

Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, Tachibana K, Ogihara T, Morishita R (2005) An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 7:108–116PubMedCrossRef

33.

Kuligowska E, Barish MA, Fenlon HM, Blake M (2001) Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology 220:757–764PubMedCrossRef

34.

Lim A, Cosgrove D (2004) Functional studies. Eur Radiol 14(Suppl 8):110–115

35.

Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK (2001) Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 57:108–111PubMedCrossRef

36.

Loch T (2004) [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer]. Urologe A 43:1377–1384PubMedCrossRef

37.

Loch T, Eppelmann U, Lehmann J, Wullich B, Loch A, Stockle M (2004) Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. World J Urol 22:357–360PubMedCrossRef

38.

Nilsson A (2004) Contrast-enhanced ultrasound of the kidneys. Eur Radiol 14(Suppl 8):104–109

39.

Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566PubMedCrossRef

40.

Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, Bartsch G, Frauscher F (2005) Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173:1926–1929PubMedCrossRef

41.

Pepe P, Patane D, Panella P, Aragona F (2003) Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer? Prostate Cancer Prostatic Dis 6:159–162PubMedCrossRef

42.

Phillips P, Gardner E (2004) Contrast-agent detection and quantification. Eur Radiol 14(Suppl 8):4–10

43.

Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE (2005) Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis. Eur Urol 48:386–399PubMedCrossRef

44.

Roy C, Buy X, Lang H, Saussine C, Jacqmin D (2003) Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 170:69–72PubMedCrossRef

45.

Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging––clinicopathologic study. Radiology 213:473–480PubMed

46.

Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, von Schulthess GK, Hany TF (2005) Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 235:623–628PubMedCrossRef

47.

Sedelaar JP, Aarnink RG, van Leenders GJ, Beerlage HP, Debruyne FM, Wijkstra H, de la Rosette JJ (2000) The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 37:559–568PubMedCrossRef

48.

Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, van der Poel HG, van der Laak JA, Debruyne FM, Wijkstra H, de la Rosette JJ (2001) Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 40:285–293PubMedCrossRef

49.

Shah JB, Reese AC, McKiernan JM, Benson MC (2005) PSA updated: still relevant in the new millennium? Eur Urol 47:427–432PubMedCrossRef

50.

Smith DS, Catalona WJ (1995) Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 45:70–74PubMedCrossRef

51.

Unal D, Sedelaar JP, Aarnink RG, van Leenders GJ, Wijkstra H, Debruyne FM, de la Rosette JJ (2000) Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 86:58–64PubMedCrossRef

52.

van der Cruijsen-Koeter IW, Wildhagen MF, de Koning HJ, Schroder FH (2001) The value of current diagnostic tests in prostate cancer screening. BJU Int 88:458–466CrossRef

53.

Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404PubMedCrossRef

54.

Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR, Villanueva FS (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine–arginine–leucine. Cancer Res 65:533–539PubMed

Title: Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer
Authors: M. H. Wink
J. J. M. C. H. de la Rosette
C. A. Grimbergen
H. Wijkstra
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 4/2007
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-007-0189-0

At a glance: The STEP trials

Springer Medicine

Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2007

Value of magnetic resonance imaging in prostate cancer diagnosis

Fluid perfused urethral pressure profilometry and Valsalva leak point pressure: a comparative study in a biophysical model of the urethra

Positron emission tomography (PET) in the urooncological evaluation of the small pelvis

Technical and anatomical essentials for transrectal ultrasound of the prostate

Evaluation of tumor thrombi in the inferior vena cava with intraoperative ultrasound

Type of renal calculi: variation with age and sex